BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 15228501)

  • 21. Olcegepant blocks neurogenic and non-neurogenic CGRPergic vasodepressor responses and facilitates noradrenergic vasopressor responses in pithed rats.
    Avilés-Rosas VH; Rivera-Mancilla E; Marichal-Cancino BA; Manrique-Maldonado G; Altamirano-Espinoza AH; Maassen Van Den Brink A; Villalón CM
    Br J Pharmacol; 2017 Jul; 174(13):2001-2014. PubMed ID: 28369749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heteroreceptors Modulating CGRP Release at Neurovascular Junction: Potential Therapeutic Implications on Some Vascular-Related Diseases.
    González-Hernández A; Marichal-Cancino BA; Lozano-Cuenca J; López-Canales JS; Muñoz-Islas E; Ramírez-Rosas MB; Villalón CM
    Biomed Res Int; 2016; 2016():2056786. PubMed ID: 28116293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcitonin gene-related peptide: physiology and pathophysiology.
    Russell FA; King R; Smillie SJ; Kodji X; Brain SD
    Physiol Rev; 2014 Oct; 94(4):1099-142. PubMed ID: 25287861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropeptide release augments serum albumin loss and reduces ultrafiltration in peritoneal dialysis.
    Cavallini N; Delbro D; Tobin G; Braide M
    Perit Dial Int; 2012; 32(2):168-76. PubMed ID: 21965619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of ionotropic glutamate receptor antagonists on rat dural artery diameter in an intravital microscopy model.
    Chan KY; Gupta S; de Vries R; Danser AH; Villalón CM; Muñoz-Islas E; Maassenvandenbrink A
    Br J Pharmacol; 2010 Jul; 160(6):1316-25. PubMed ID: 20590623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974).
    Sinclair SR; Kane SA; Van der Schueren BJ; Xiao A; Willson KJ; Boyle J; de Lepeleire I; Xu Y; Hickey L; Denney WS; Li CC; Palcza J; Vanmolkot FH; Depré M; Van Hecken A; Murphy MG; Ho TW; de Hoon JN
    Br J Clin Pharmacol; 2010 Jan; 69(1):15-22. PubMed ID: 20078608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The nonpeptide calcitonin gene-related peptide receptor antagonist BIBN4096BS lowers the activity of neurons with meningeal input in the rat spinal trigeminal nucleus.
    Fischer MJ; Koulchitsky S; Messlinger K
    J Neurosci; 2005 Jun; 25(25):5877-83. PubMed ID: 15976076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and potential of non-peptide antagonists for calcitonin-gene-related peptide (CGRP) receptors: evidence for CGRP receptor heterogeneity.
    Wu D; Doods H; Arndt K; Schindler M
    Biochem Soc Trans; 2002 Aug; 30(4):468-73. PubMed ID: 12196117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of BIBN4096BS on cardiac output distribution and on CGRP-induced carotid haemodynamic responses in the pig.
    Kapoor K; Arulmani U; Heiligers JP; Willems EW; Doods H; Villalón CM; Saxena PR
    Eur J Pharmacol; 2003 Aug; 475(1-3):69-77. PubMed ID: 12954361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors--the role of receptor activity modifying protein 1.
    Hay DL; Christopoulos G; Christopoulos A; Sexton PM
    Mol Pharmacol; 2006 Dec; 70(6):1984-91. PubMed ID: 16959943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding properties of the novel, non-peptide CGRP receptor antagonist radioligand, [(3)H]BIBN4096BS.
    Schindler M; Doods HN
    Eur J Pharmacol; 2002 May; 442(3):187-93. PubMed ID: 12065071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcitonin gene-related peptide and its role in migraine pathophysiology.
    Arulmani U; Maassenvandenbrink A; Villalón CM; Saxena PR
    Eur J Pharmacol; 2004 Oct; 500(1-3):315-30. PubMed ID: 15464043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment.
    Moreno MJ; Abounader R; Hébert E; Doods H; Hamel E
    Neuropharmacology; 2002 Mar; 42(4):568-76. PubMed ID: 11955527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS on alpha-CGRP-induced regional haemodynamic changes in anaesthetised rats.
    Arulmani U; Schuijt MP; Heiligers JP; Willems EW; Villalón CM; Saxena PR
    Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):291-7. PubMed ID: 15228501
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.